% Expired Patents = 16.7

EPO Patents = 2

Forward Citations = 7

Loading Chart...

5 inventors (with patents filed for the assignee):

Matthias Steger (6 out of 8 patents)

Alex Mueller (6 out of 6 patents)

Mauro Marigo (4 out of 4 patents)

4. Bernhard Fasching (3 out of 3 patents)

5. Daphna Mokady (3 out of 3 patents)

6 patents: Sort by Forward Citations

1. 12630542 - Compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium (2026-05-19),

2. 12195452 - N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compounds as stimulators of the production of retinal precursor cells for the treatment of neuroretinal diseases (2025-01-14),

3. 11844755 - Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epithelium (2023-12-19),

4. 11541039 - Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epithelium (2023-01-03),

5. 10807973 - Compounds for use as therapeutically active substances in the treatment of retinal diseases (2020-10-20),

6. 10752593 - Compounds for use as therapeutically active substances in the treatment of retinal diseases (2020-08-25),

Company Overview

Endogena Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for the treatment of cardiovascular and metabolic diseases. Our innovative research and development efforts aim to address significant unmet medical needs and improve patient outcomes. Visit our website to learn more about our cutting-edge approach to drug discovery and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#666 in San Francisco, CA

#10,570 in California

#44,981 in US

San Francisco, CA, United States of America

Endogena Therapeutics, Inc.

Forward Citations = 7

5 inventors:

Matthias Steger (6 out of 8 patents)

Alex Mueller (6 out of 6 patents)

Mauro Marigo (4 out of 4 patents)

4. Bernhard Fasching (3 out of 3 patents)

5. Daphna Mokady (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Endogena Therapeutics, Inc.. Retrieved from https://idiyas.com/company/endogena-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]